Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Focal adhesion kinase: from biological functions to therapeutic strategies
Ximin Tan, Yuheng Yan, Bin Song, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 51
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
Qing Wei, Peijing Li, Teng Yang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 50
Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance
Jing Wang, Baizhou Li, Meng Luo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions
R. Gerosa, Rita De Sanctis, Flavia Jacobs, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104324-104324
Open Access | Times Cited: 19
Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies
Nating Xiong, Heming Wu, Zhikang Yu
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 19
Targeting triple negative breast cancer stem cells using nanocarriers
Nagasen Dasari, Girijasankar Guntuku, Sai Kiran S. S. Pindiprolu
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021
Tianye Li, Haoxiang Zhang, Mengyi Lian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Platycodon grandiflorum-derived extracellular vesicles suppress triple-negative breast cancer growth by reversing the immunosuppressive tumor microenvironment and modulating the gut microbiota
Min Yang, Jia Guo, Jinxian Li, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
“Triple-Punch” Strategy Exosome-Mimetic Nanovesicles for Triple Negative Breast Cancer Therapy
Chenhong Zhang, Shuangshuang Tang, Meilin Wang, et al.
ACS Nano (2024)
Closed Access | Times Cited: 14
The immune checkpoint TIGIT/CD155 promotes the exhaustion of CD8 + T cells in TNBC through glucose metabolic reprogramming mediated by PI3K/AKT/mTOR signaling
Mingyao Huang, Xiaoqin Yu, Qing Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Multiple Treatment of Triple‐Negative Breast Cancer Through Gambogic Acid‐Loaded Mesoporous Polydopamine
Jiaqi Liu, Hongmei Liu, Shan Huang, et al.
Small (2024) Vol. 20, Iss. 31
Closed Access | Times Cited: 11
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice
Ling Zhou, Yunlong Lu, Wei Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10
The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy
Peng Huang, Feng Wen, YiShan Li, et al.
Life Sciences (2024) Vol. 344, pp. 122576-122576
Closed Access | Times Cited: 9
POP1 Facilitates Proliferation in Triple-Negative Breast Cancer via m6A-Dependent Degradation of CDKN1A mRNA
Chao Zhang, Sifen Wang, Xiuqing Lu, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 8
pH/GSH dual-responsive nanoparticle for auto-amplified tumor therapy of breast cancer
Shengnan Huang, Zhi-ling Xu, Weiwei Zhi, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Ximin Tan, Deguang Kong, Zhuoli Tao, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Recent Developments in Combination Immunotherapy with Other Therapies and Nanoparticle-Based Therapy for Triple-Negative Breast Cancer (TNBC)
Gantumur Battogtokh, Onyinyechi Obidiro, Emmanuel O. Akala
Cancers (2024) Vol. 16, Iss. 11, pp. 2012-2012
Open Access | Times Cited: 4
Ziziphus mauritiana Leaf Extract Induces ROS-dependent Apoptosis by Downregulation of CD81 in MDA- MB 231 Triple Negative Breast Cancer Cells
Dian Lestari, Gondo Mastutik, Indri Safitri Mukono
Research Square (Research Square) (2025)
Closed Access
Advancements in understanding the role and mechanism of sirtuin family (SIRT1-7) in breast cancer management
Deepak Kumar Sharma, Muthukumaran Panchaksaram, Rajiniraja Muniyan
Biochemical Pharmacology (2025) Vol. 232, pp. 116743-116743
Closed Access
The analysis of gene co-expression network and immune infiltration revealed biomarkers between triple-negative and non-triple negative breast cancer
Yi Yao, Yu Zhong, Lu Xie, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications
Ana Isabel Sebastião, Gabriel Chahade Sibanto Simões, Filomena Oliveira, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102884-102884
Open Access
Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist
Guodong Li, Ruoxin Du, Donghui Wang, et al.
Advanced Science (2025)
Open Access
Mechanistic insights into pachymic acid’s action on triple-negative breast Cancer through TOP2A targeting
Ming Liu, Li Zheng, Yang Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Anti-proliferative and Pro-apoptotic Activity of a Novel Oil-in-Water Nanoemulsion Containing Tea Tree Oil, Quercetin, and Rosmarinic Acid in Breast Cancer Cells
Esther Medina-Magariño, Juan Manuel Pinos‐Rodríguez, Ángel Pulido‐Capiz, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Open Access
Understanding of chemotherapeutic resistance: With special reference to breast cancer
Harmanjit Singh, Dwividendra Kumar Nim, Pankaj Kumar, et al.
Elsevier eBooks (2025), pp. 173-206
Closed Access
Page 1 - Next Page

Scroll to top